Merck & Co (MRK) Shareholder Rowland & Company Investment Counsel Decreased Position; As Air Lease (AL) Stock Price Declined, Boston Partners Increased Stake by $8.16 Million

Merck & Co., Inc. (NYSE:MRK) Logo

Rowland & Company Investment Counsel decreased its stake in Merck & Co Inc (MRK) by 0.82% based on its latest 2018Q3 regulatory filing with the SEC. Rowland & Company Investment Counsel sold 400 shares as the company’s stock rose 11.30% while stock markets declined. The institutional investor held 48,235 shares of the health care company at the end of 2018Q3, valued at $3.42B, down from 48,635 at the end of the previous reported quarter. Rowland & Company Investment Counsel who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $205.48B market cap company. The stock increased 0.64% or $0.5 during the last trading session, reaching $79.02. About 10.48 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 41.35% since February 14, 2018 and is uptrending. It has outperformed by 41.35% the S&P500. Some Historical MRK News: 18/05/2018 – U.S. FDA SAYS THERE WAS NO CHANGE IN THE ADVERSE EVENT PROFILE OF KEYTRUDA OR TECENTRIQ; 23/04/2018 – EMA VALIDATES TYPE II VARIATION FOR MERCK & CO’S KEYTRUDA; 03/04/2018 – EMA ACCEPTS REGULATORY SUBMISSION FOR LYNPARZA® (OLAPARIB) IN; 09/04/2018 – Merck: Studdy As Monotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer; 09/04/2018 – KEYTRUDA® (pembrolizumab) Monotherapy Met Primary Endpoint in Phase 3 KEYNOTE-042 Study, Significantly Improving OS as First-Line Therapy in Locally Advanced or Metastatic NSCLC Patients Expressing PD-L1 in at Least 1 Percent of Tumor; 17/04/2018 – Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018; 16/05/2018 – Merck KGaA’s lung cancer drugs show promise in early-stage trials; 02/05/2018 – Merck, Pfizer Deliver Checkup on Pharma Sector (Video); 09/04/2018 – #2 Merck racks up another win in wide-ranging PhIII Keytruda lung cancer study, this time as solo therapy $MRK $BMY; 27/03/2018 – ADVISORY-Alerts on Merck & Co’s fast-track designation for tepotinib withdrawn

Boston Partners increased its stake in Air Lease Corp (AL) by 2.08% based on its latest 2018Q3 regulatory filing with the SEC. Boston Partners bought 181,291 shares as the company’s stock declined 22.14% with the market. The institutional investor held 8.91M shares of the diversified commercial services company at the end of 2018Q3, valued at $408.85 million, up from 8.73 million at the end of the previous reported quarter. Boston Partners who had been investing in Air Lease Corp for a number of months, seems to be bullish on the $4.24 billion market cap company. The stock decreased 0.05% or $0.02 during the last trading session, reaching $38.18. About 603,982 shares traded. Air Lease Corporation (NYSE:AL) has declined 19.59% since February 14, 2018 and is downtrending. It has underperformed by 19.59% the S&P500. Some Historical AL News: 10/05/2018 – AIR LEASE SEES AIRCRAFT IN SHORT SUPPLY OVER NEXT 3-4 YEARS; 09/04/2018 – AIR LEASE CORPORATION ANNOUNCES LEASE PLACEMENT OF AIRBUS A330-900NEO WITH Hl FLY; 03/04/2018 – Boeing, Air Lease Corporation Sign Order for Eight 737 MAX Airplanes; 14/05/2018 – Air Lease Presenting at Barclays Conference May 16; 10/05/2018 – AIR LEASE WOULD CONSIDER ASSET PURCHASES FROM OTHER LESSORS; 10/05/2018 – AIR LEASE TO DELIVER 121 NEW AIRCRAFT THRU END OF 2019; 03/05/2018 – Air Lease Corporation Increases Unsecured Revolving Credit Facility to $4.5 Billion; 10/05/2018 – Air Lease 1Q EPS $1.00; 10/05/2018 – AIR LEASE CORP FILES MIXED SECURITIES SHELF; 09/04/2018 – AIR LEASE CORP – ANNOUNCED A MEDIUM-TERM LEASE AGREEMENT WITH Hl FLY (PORTUGAL) FOR ONE ROLLS-ROYCE TRENT 7000-POWERED AIRBUS A330-900NEO AIRCRAFT

Another recent and important Air Lease Corporation (NYSE:AL) news was published by which published an article titled: “Air Lease Corporation Announces Lease Placement of Four New Boeing 737 MAX 8 Aircraft with Caribbean Airlines – Business Wire” on February 11, 2019.

Boston Partners, which manages about $53.18B and $86.06 billion US Long portfolio, decreased its stake in Synchrony Finl (NYSE:SYF) by 1.09M shares to 6.49 million shares, valued at $201.85M in 2018Q3, according to the filing. It also reduced its holding in Assured Guaranty Ltd (NYSE:AGO) by 36,011 shares in the quarter, leaving it with 1.82 million shares, and cut its stake in Fluor Corp New (NYSE:FLR).

Investors sentiment increased to 1.18 in Q3 2018. Its up 0.03, from 1.15 in 2018Q2. It is positive, as 21 investors sold AL shares while 86 reduced holdings. 45 funds opened positions while 81 raised stakes. 88.88 million shares or 2.10% more from 87.05 million shares in 2018Q2 were reported. The New Jersey-based Bessemer Gp has invested 0% in Air Lease Corporation (NYSE:AL). Farmers And Merchants Invs reported 396 shares. Utah Retirement reported 0.02% of its portfolio in Air Lease Corporation (NYSE:AL). Buffington Mohr Mcneal stated it has 122,670 shares. Northern Tru owns 1.26 million shares. Advsrs Asset has invested 0% in Air Lease Corporation (NYSE:AL). Reinhart Prns Inc reported 0.35% in Air Lease Corporation (NYSE:AL). Voya Mgmt Ltd Liability Corp holds 0% or 20,723 shares in its portfolio. Bancshares Of New York Mellon Corp stated it has 592,208 shares. Nordea Inv Management Ab holds 0% or 36,900 shares in its portfolio. Chicago Equity Ptnrs Limited Company reported 0.04% in Air Lease Corporation (NYSE:AL). Ubs Asset Management Americas holds 107,856 shares or 0% of its portfolio. Quantitative Invest Mngmt Lc reported 10,900 shares or 0.02% of all its holdings. Beach Inv Management Limited Liability Co reported 30,310 shares. Fifth Third Bankshares reported 0.01% in Air Lease Corporation (NYSE:AL).

Since August 21, 2018, it had 3 insider purchases, and 3 sales for $1.17 million activity. The insider Levy Grant A sold 15,000 shares worth $676,973. $102,870 worth of Air Lease Corporation (NYSE:AL) was bought by UDVAR-HAZY STEVEN F on Friday, December 14. $462,236 worth of Air Lease Corporation (NYSE:AL) was sold by Baer Marc H.

Among 13 analysts covering Air Lease (NYSE:AL), 10 have Buy rating, 1 Sell and 2 Hold. Therefore 77% are positive. Air Lease had 50 analyst reports since August 7, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Buy” rating in Friday, February 23 report. FBR Capital maintained Air Lease Corporation (NYSE:AL) rating on Friday, May 5. FBR Capital has “Outperform” rating and $45 target. Citigroup maintained Air Lease Corporation (NYSE:AL) on Wednesday, August 15 with “Neutral” rating. Cowen & Co maintained Air Lease Corporation (NYSE:AL) rating on Friday, November 10. Cowen & Co has “Outperform” rating and $54 target. The firm has “Overweight” rating given on Friday, November 13 by JP Morgan. The stock has “Buy” rating by RBC Capital Markets on Friday, May 26. The firm earned “Outperform” rating on Monday, December 28 by Credit Suisse. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Thursday, April 6. The rating was maintained by Morgan Stanley on Wednesday, November 14 with “Equal-Weight”. The stock of Air Lease Corporation (NYSE:AL) has “Outperform” rating given on Friday, November 4 by FBR Capital.

Investors sentiment decreased to 0.93 in 2018 Q3. Its down 0.07, from 1 in 2018Q2. It is negative, as 41 investors sold MRK shares while 628 reduced holdings. 132 funds opened positions while 490 raised stakes. 1.87 billion shares or 0.48% less from 1.88 billion shares in 2018Q2 were reported. Longer Incorporated reported 35,775 shares. Cornerstone Capital reported 7,916 shares. Stralem & Communication invested in 3.32% or 157,711 shares. Stock Yards Financial Bank has 52,337 shares. Wealthtrust invested in 3,051 shares. Eos Mgmt LP accumulated 6,979 shares or 0.73% of the stock. Blair William And Il holds 0.18% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 410,610 shares. Central Secs Corp holds 200,000 shares. Broderick Brian C invested 0.47% of its portfolio in Merck & Co., Inc. (NYSE:MRK). D E Shaw holds 6.00M shares. Barr E S & reported 6,158 shares. Stillwater Capital Advisors Limited Liability Com holds 3.66% or 248,579 shares in its portfolio. Ashford Cap reported 5,300 shares stake. 34,679 are owned by Hall Laurie J Trustee. Hugh Johnson Advsr reported 9,751 shares.

More important recent Merck & Co., Inc. (NYSE:MRK) news were published by: which released: “New Research: Key Drivers of Growth for Merck & Co., ON Semiconductor, General Mills, Prudential Financial, Nanometrics, and Echo Global Logistics — Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” on February 08, 2019, also published article titled: “Merck’s Keytruda improves survival in certain esophageal cancer patients – Seeking Alpha”, published: “Merck: Keytruda Contribution Finally Fairly Valued – Seeking Alpha” on February 04, 2019. More interesting news about Merck & Co., Inc. (NYSE:MRK) was released by: and their article: “Why I Plan To Buy Merck – Seeking Alpha” with publication date: February 14, 2019.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart